Abstract
Tumor-associated macrophages (TAM) play a critical role in promoting tumor development and metastasis. In the present study, we found that legumain, an asparaginyl endopeptidase, was highly expressed on the surface of TAM. A doxorubicin-based prodrug specifically activated by legumain selectively ablated TAM and resulted in a significant reduction of angiogenic factors and related tumor vessel growth. Treatment with the prodrug also suppressed circulating tumor cells and myeloid immune suppressor Gr-1+/CD11b+ cells in tumor-bearing animals. After selective ablation of TAM using the prodrug, tumor growth and metastases were greatly inhibited in murine tumor models. These results indicate that legumain-activated prodrugs targeting TAM in tumors might represent a novel anticancer strategy. © 2013 Japanese Cancer Association.
Cite
CITATION STYLE
Lin, Y., Wei, C., Liu, Y., Qiu, Y., Liu, C., & Guo, F. (2013). Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis. Cancer Science, 104(9), 1217–1225. https://doi.org/10.1111/cas.12202
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.